Exforge HCT medication

Exforge HCT is a high-prescription medication used for the treatment of hypertension. It is a triple-combination drug consisting of amlodipine, valsartan, and hydrochlorothiazide. The brand was developed by Novartis, a leading global pharmaceutical company headquartered in Basel, Switzerland.

While Novartis operates manufacturing facilities worldwide, including major hubs in Germany, Ireland, and the United States, Exforge HCT is historically associated with Swiss pharmaceutical engineering. The brand remains under the ultimate ownership of Novartis AG, which manages its global distribution through various regional subsidiaries.